Hikma Pharmaceuticals PLC (HIK) — Working Capital to Net Assets Ratio

Latest as of June 2025: 19.6%

Hikma Pharmaceuticals PLC (HIK) has a Working Capital to Net Assets ratio of 19.6% as of June 2025. Working capital of GBX501.00 Million (current assets of GBX2.56 Billion minus current liabilities of GBX2.06 Billion) is measured against net assets of GBX2.55 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Hikma Pharmaceuticals PLC net asset quality index to measure how much of total assets are equity-financed.

WC/NA Ratio

19.6%
Working Capital / Net Assets

Working Capital

GBX501.00 Million
GBX

Current Assets

GBX2.56 Billion
GBX

Current Liabilities

GBX2.06 Billion
GBX

Hikma Pharmaceuticals PLC Working Capital to Net Assets (2002–2024)

This chart shows how Hikma Pharmaceuticals PLC's Working Capital to Net Assets ratio has evolved across 23 annual periods from 2002 to 2024. As of June 2025, the ratio stands at 19.6%, reflecting working capital of GBX501.00 Million against net assets of GBX2.55 Billion GBX. Check Hikma Pharmaceuticals PLC tangible book value ratio to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Hikma Pharmaceuticals PLC (2002–2024)

The table below presents the year-by-year Working Capital to Net Assets ratio for Hikma Pharmaceuticals PLC from 2002 to 2024, covering 23 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see HIK stock market capitalisation.

Year WC/NA Ratio Working Capital (GBX) Net Assets Current Assets Current Liabilities Change (pp)
2024 12.3% GBX285.00 Million GBX2.32 Billion GBX2.26 Billion GBX1.98 Billion ▼ -22.2 pp
2023 34.4% GBX761.00 Million GBX2.21 Billion GBX2.10 Billion GBX1.34 Billion ▼ -8.5 pp
2022 42.9% GBX922.00 Million GBX2.15 Billion GBX2.00 Billion GBX1.08 Billion ▼ -0.8 pp
2021 43.7% GBX1.08 Billion GBX2.47 Billion GBX2.09 Billion GBX1.02 Billion ▲ +2.1 pp
2020 41.6% GBX894.00 Million GBX2.15 Billion GBX1.92 Billion GBX1.03 Billion ▲ +23.9 pp
2019 17.7% GBX377.00 Million GBX2.13 Billion GBX1.85 Billion GBX1.47 Billion ▼ -28.0 pp
2018 45.7% GBX775.00 Million GBX1.70 Billion GBX1.67 Billion GBX893.00 Million ▼ -5.2 pp
2017 50.9% GBX777.00 Million GBX1.53 Billion GBX1.57 Billion GBX797.00 Million ▲ +28.9 pp
2016 22.0% GBX530.00 Million GBX2.41 Billion GBX1.45 Billion GBX918.00 Million ▼ -34.8 pp
2015 56.8% GBX768.00 Million GBX1.35 Billion GBX1.36 Billion GBX592.00 Million ▲ +42.7 pp
2014 14.1% GBX172.00 Million GBX1.22 Billion GBX1.01 Billion GBX841.00 Million ▼ -15.9 pp
2013 30.1% GBX311.00 Million GBX1.03 Billion GBX897.00 Million GBX586.00 Million ▼ -7.1 pp
2012 37.2% GBX315.01 Million GBX847.85 Million GBX781.97 Million GBX466.95 Million ▲ +3.4 pp
2011 33.7% GBX269.30 Million GBX798.63 Million GBX659.88 Million GBX390.58 Million ▲ +3.7 pp
2010 30.1% GBX225.49 Million GBX750.30 Million GBX494.12 Million GBX268.62 Million ▼ -6.9 pp
2009 36.9% GBX252.16 Million GBX683.26 Million GBX456.60 Million GBX204.44 Million ▲ +6.2 pp
2008 30.7% GBX186.77 Million GBX609.00 Million GBX415.21 Million GBX228.43 Million ▲ +37.2 pp
2007 -6.6% GBX-27.84 Million GBX424.66 Million GBX366.20 Million GBX394.04 Million ▼ -61.8 pp
2006 55.2% GBX193.11 Million GBX349.80 Million GBX299.83 Million GBX106.73 Million ▼ -17.2 pp
2005 72.4% GBX208.24 Million GBX287.48 Million GBX284.94 Million GBX76.70 Million ▲ +12.3 pp
2004 60.1% GBX87.24 Million GBX145.18 Million GBX160.48 Million GBX73.23 Million ▼ -9.9 pp
2003 70.0% GBX42.36 Million GBX60.47 Million GBX80.35 Million GBX38.00 Million ▲ +12.3 pp
2002 57.8% GBX27.74 Million GBX48.03 Million GBX64.37 Million GBX36.63 Million —
pp = percentage points